Fundz

Ocudyne

Brooklyn Park, Minnesota, United States · Healthcare, Health Care

OcuDyne is a clinical-stage medical device company developing a novel therapy to treat Age Related Macular Degeneration (AMD), the leading cause of irreversible vision loss in the elderly worldwide. As a world leader in the evaluation of ocular perfusion and how it influences ocular health, OcuDyne’s mission is to develop therapies that improve blood flow to the eye. Impaired blood flow causes

Key facts

Headquarters
Brooklyn Park, Minnesota, United States
Employees
4
Industries
Healthcare, Health Care
Status
Private
Website
ocudyne.com
LinkedIn
Company page

Recent activity at Ocudyne

Ocudyne funding history

DateRoundAmount
Mar 2025Venture$5.7M
Feb 2019Seed$2.0M
Aug 2017Seed$886K
Oct 2016Seed$463K

Leadership

  • Robert Atkinson, Executive Officer, Director
  • Joseph Smith, Director
  • Jeffrey Franco, Executive Officer, Director
  • Jeff Franco, Executive Officer, Director

Verified email and direct lines for Ocudyne’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

Ocudyne files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Ocudyne in the news

Companies similar to Ocudyne

About Ocudyne: questions and answers

What does Ocudyne do?

OcuDyne is a clinical-stage medical device company developing a novel therapy to treat Age Related Macular Degeneration (AMD), the leading cause of irreversible vision loss in the elderly worldwide. As a world leader in the evaluation of ocular perfusion and how it influences ocular health, OcuDyne’s mission is to develop therapies that improve blood flow to the eye. Impaired blood flow causes

Where is Ocudyne headquartered?

Ocudyne is headquartered in Brooklyn Park, Minnesota, United States.

How many employees does Ocudyne have?

Ocudyne has about 4 employees.

Has Ocudyne raised funding?

Yes. Fundz has recorded 4 funding events for Ocudyne. The most recent, $5.7M, was in Mar 2025.

What is the latest news on Ocudyne?

On Mar 06, 2025, Ocudyne

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Ocudyne across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.